Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Seps
You must be logged in to create a new article
All Articles
Scott Mckeown
Jan 9, 2019
•
Featured
Dealing with SEP Demands & Royalty Stacking
Seeking More Granularity on Patent Pools? Patent pools and groupings of standard essential patents (SEPs) facilitate one-stop shopping of patent... Read More
Ann Conkle
Feb 7, 2012
Infant meningococcal vaccination appears effective
A vaccine for serogroup B Neisseria meningitidis (MenB), a bacterium that causes of serious disease such as sepsis and meningitis,... Read More
Alejandro Freixes
Oct 25, 2011
Lillly pulls sepsis drug Xigris, no benefit found
  By Lewis Krauskopf and Ransdell Pierson               (Reuters) - Eli Lilly and Co... Read More